超越活检:非整倍体植入前遗传学检测后决策后悔与焦虑的预测因素
该研究对2014年1月至2015年3月期间首次接受自体PGT-A的395例患者进行匿名调查,69例完成问卷。多数患者对PGT-A持正面看法,但结局阴性者决策后悔和焦虑更重;无整倍体胚胎与后悔增加相关,整倍体移植后未孕或流产者后悔高于成功妊娠者(P<0.005),焦虑在妊娠试验阴性或流产后高于成功妊娠(P<0.0001)。
要点
- 总体决策后悔评分低,94%受访者对选择PGT-A表示满意。
- 无整倍体胚胎者后悔更重;整倍体移植后流产或未孕者后悔高于成功妊娠者(P<0.005)。
- 妊娠试验阴性或流产后焦虑高于成功妊娠(P<0.0001)。
核心结论
- PGT-A后总体决策后悔低,绝大多数认为所获信息对生育规划有价值,但超过三分之一受访者表达某种程度的后悔。
- 无整倍体胚胎者更可能表达后悔,整倍体胚胎移植后结局阴性者后悔和焦虑均更高。
- 这些数据揭示了PGT-A的意外后果,提示可围绕IVF联合PGT-A提供额外咨询和支持。
研究设计与样本
- 匿名问卷调查,2014年1月至2015年3月期间首次接受自体PGT-A的395例患者中69例完成问卷并符合纳入标准。
- 在一所大学附属生育中心开展,问卷包括Brehaut决策后悔量表、简式状态-特质焦虑量表(STAI-6)和健康素养量表。
主要发现
- 总体决策后悔中位评分低,但39%受访者表达某种程度的后悔。
- 多元回归证实胚胎倍性与决策后悔相关,整倍体胚胎数量越少后悔程度越高。
- 整倍体移植后妊娠者后悔低于流产或未孕者(P<0.005)。
- 决策后悔与存活子女数呈负相关,与年龄、教育、种族、保险覆盖、宗教、婚姻状况或IVF/PGT-A指征无关。
- 妊娠试验阴性或流产后焦虑高于成功妊娠(P<0.0001);焦虑与年龄、取卵后时间及存活子女数呈负相关,并与宗教归属存在关联。
关键数值与推荐
- 94%受访者报告对选择PGT-A的决定感到满意。
- 39%受访者表达某种程度的决策后悔。
- 整倍体移植后妊娠者后悔低于流产或未孕者(P<0.005)。
- 妊娠试验阴性或流产后焦虑高于成功妊娠(P<0.0001)。
临床怎么用
- 作者认为这些数据提示可围绕IVF联合PGT-A提供额外咨询和支持。
局限性
- 调查在单一中心开展,人群相对同质, findings可能不可推广。
- 需谨慎的原因包括可能存在应答偏倚、应答者与未应答者之间存在未测量的差异。
- 鉴于调查的回顾性性质,可能存在回忆偏倚。
- 考察患者对PGT-A认知的研究较少, findings应谨慎解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: What factors are associated with decision regret and anxiety following preimplantation genetic testing for aneuploidy (PGT-A)? SUMMARY ANSWER: The majority of patients viewed PGT-A favourably regardless of their outcome; although patients with negative outcomes expressed greater decision regret and anxiety. WHAT IS KNOWN ALREADY: PGT-A is increasingly utilized in in vitro fertilization (IVF) cycles to aid in embryo selection. Despite the increasing use of PGT-A technology, little is known about patients' experiences and the possible unintended consequences of decision regret and anxiety related to PGT-A outcome. STUDY DESIGN, SIZE, DURATION: Anonymous surveys were distributed to 395 patients who underwent their first cycle of autologous PGT-A between January 2014 and March 2015. PARTICIPANTS/MATERIALS, SETTING, METHODS: There were 69 respondents who underwent PGT-A at a university-affiliated fertility centre, completed the survey and met inclusion criteria. Respondents completed three validated questionnaires including the Brehaut Decision Regret (DR) Scale, short-form State-Trait Anxiety Inventory (STAI-6) and a health literacy scale. The surveys also assessed demographics, fertility history, IVF and frozen embryo transfer cycle data. MAIN RESULTS AND THE ROLE OF CHANCE: The majority of respondents were Caucasian, >35 years of age and educated beyond an undergraduate degree. The majority utilized PGT-A on their first IVF cycle, most commonly to 'maximize the efficiency of IVF' or reduce per-transfer miscarriage risk. The overall median DR score was low, but 39% of respondents expressed some degree of regret. Multiple regression confirmed a relationship between embryo ploidy and decision regret, with a lower number of euploid embryos associated with a greater degree of regret. Patients who conceived following euploid transfer reported less regret than those who miscarried or failed to conceive (P < 0.005). Decision regret was inversely associated with number of living children but not associated with age, education, race, insurance coverage, religion, marital status or indication for IVF/PGT-A. Anxiety was greater following a negative pregnancy test or miscarriage compared to successful conception (P < 0.0001). Anxiety was negatively associated with age, time since oocyte retrieval and number of living children, and a relationship was observed between anxiety and religious affiliation. Overall, decision regret was low, and 94% of all respondents reported satisfaction with their decision to pursue PGT-A; however, patients with a negative outcome were more likely to express decision regret and anxiety. LIMITATIONS, REASON FOR CAUTION: This survey was performed at a single centre with a relatively homogenous population, and the findings may not be generalizable. Reasons for caution include the possibility of response bias and unmeasured differences among those who did and did not respond to the survey, as well as the possibility of recall bias given the retrospective nature of the survey. Few studies have examined patient perceptions of PGT-A, and our findings should be interpreted with caution. WIDER IMPLICATIONS OF THE FINDINGS: Overall decision regret was low following PGT-A, and the vast majority deemed the information gained valuable for reproductive planning regardless of outcome. However, more than one-third of the respondents expressed some degree of regret. Respondents with no euploid embryos were more likely to express regret, and those with a negative outcome following euploid embryo transfer expressed both higher regret and anxiety. These data identify unanticipated consequences of PGT-A and suggest opportunities for additional counselling and support surrounding IVF with PGT-A. STUDY FUNDING/COMPETING INTEREST(S): No external funding was obtained for this study. D.H.M. reports personal fees, honorarium, and travel expenses from Ferring Pharmaceuticals, personal fees and travel expenses from Granata Bio, and personal fees from Biogenetics Corporation, The Sperm and Embryo Bank of New York, and ReproART: Georgian American Center for Reproductive Medicine. All conflicts are outside the submitted work.
引用
- Goldman KN, Blakemore J, Kramer Y, et al. Beyond the biopsy: predictors of decision regret and anxiety following preimplantation genetic testing for aneuploidy. Hum Reprod. 2019. PMID: 31220868. doi:10.1093/humrep/dez080
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。